Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12188/8119
DC FieldValueLanguage
dc.contributor.authorPereska Zaninaen_US
dc.contributor.authorJanicevic-Ivanovska Danijelaen_US
dc.contributor.authorBekjarovski Nikoen_US
dc.contributor.authorSimonovska, Natashaen_US
dc.contributor.authorBabuloska Aleksandraen_US
dc.date.accessioned2020-05-15T07:32:34Z-
dc.date.available2020-05-15T07:32:34Z-
dc.date.issued2019-06-
dc.identifier.urihttp://hdl.handle.net/20.500.12188/8119-
dc.description.abstractObjective. The overlapping of pharmacokinetics and/or the pharmacodynamics of medicines causes the occurrence of overlapping clinical syndromes and diagnostic issues, potentiated in overdoses. We report a case of severe venlafaxine poisoning where the clinical presentation and the results of rapid immunoassay test overlapped with tramadol intoxication. Case presentation. An unconscious women with recurrent seizers, hypertension and supposed acute medication poisoning in suicidal attempt was transported to our clinic. Previously, she had been lavaged, rehydrated and treated with 20 mg diazepam iv, 40 mg furosemide at the local general hospital. Her regular tablet therapy consisted of losartan, levothyroxine, venlafaxine, occasionally tramadol. At admission she was comatose, with isochoric normal pupils, BP 130/80 mm Hg, SaO2 86%, and recurrent episodes of seizures treated with 10mg diazepam iv, ocular clonus, hypertonus, temperature 38.9C, diaphoresis, facial hyperaemia, dark coloured urine, hyponatremia and rhabdomyolisis. The lateral flow immunoassay (AbuGnostR) was positive for tramadol, but the homogeneous enzyme immunoassay did not confirm it. After 36 hours of intensive treatment she became somnolent and reported ingestion of 2250 mg tbl Venlafaxine. The AbuGnost R test detects tramadol at cut off urine values 200ng/ml, but present cross reactivity with O-desmethyl￾venlafaxine at cut off values up to 25000ng/ml. The following days she complained of muscular weakness, headaches and cognitive impairment, which lasted for more then one month after release from hospital. Conclusion. High concentrations of venlafaxine metabolites induce false positive tramadol immunoassay (AbuGnostR) test. Overlapping clinical presentations and metabolic pathways of venlafaxine and tramadol should alert physicians when interpret rapid immunoassay test. The mandatory principle when making medical decisions should cover synthesis of critically interpreted toxicology analysis, interview data and clinical features of the poisoning, which may help to avoid misleading conclusions and improve the diagnostic and therapy decisions.en_US
dc.language.isoenen_US
dc.relation.ispartofKnowledge - International Journalen_US
dc.subjectvenlafaxineen_US
dc.subjecttramadolen_US
dc.subjectpoisoningen_US
dc.subjectlateral flow immunoassayen_US
dc.titleACUTE VENLAFAXINE OVERDOSE WITH POSITIVE URINE IMMUNOASSAY FOR TRAMADOL – CLINICAL AND DIAGNOSTIC OVERLAP - CASE REPORT AND LITERATURE OVERVIEWen_US
dc.typeArticleen_US
dc.identifier.volume31-
dc.identifier.issue4-
item.grantfulltextopen-
item.fulltextWith Fulltext-
crisitem.author.deptFaculty of Medicine-
crisitem.author.deptFaculty of Medicine-
crisitem.author.deptFaculty of Medicine-
Appears in Collections:Faculty of Medicine: Journal Articles
Files in This Item:
File Description SizeFormat 
Knowledge 2019.pdf424.77 kBAdobe PDFThumbnail
View/Open
Show simple item record

Page view(s)

121
checked on Apr 24, 2024

Download(s)

65
checked on Apr 24, 2024

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.